1. Home
  2. AMPH vs IART Comparison

AMPH vs IART Comparison

Compare AMPH & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • IART
  • Stock Information
  • Founded
  • AMPH 1996
  • IART 1989
  • Country
  • AMPH United States
  • IART United States
  • Employees
  • AMPH N/A
  • IART N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • IART Medical/Dental Instruments
  • Sector
  • AMPH Health Care
  • IART Health Care
  • Exchange
  • AMPH Nasdaq
  • IART Nasdaq
  • Market Cap
  • AMPH 1.2B
  • IART 1.2B
  • IPO Year
  • AMPH 2014
  • IART 1995
  • Fundamental
  • Price
  • AMPH $26.05
  • IART $11.69
  • Analyst Decision
  • AMPH Buy
  • IART Hold
  • Analyst Count
  • AMPH 6
  • IART 7
  • Target Price
  • AMPH $35.17
  • IART $15.00
  • AVG Volume (30 Days)
  • AMPH 453.0K
  • IART 1.2M
  • Earning Date
  • AMPH 11-06-2025
  • IART 10-30-2025
  • Dividend Yield
  • AMPH N/A
  • IART N/A
  • EPS Growth
  • AMPH N/A
  • IART N/A
  • EPS
  • AMPH 2.27
  • IART N/A
  • Revenue
  • AMPH $723,305,000.00
  • IART $1,642,966,000.00
  • Revenue This Year
  • AMPH $0.74
  • IART $3.51
  • Revenue Next Year
  • AMPH $5.63
  • IART $2.88
  • P/E Ratio
  • AMPH $11.48
  • IART N/A
  • Revenue Growth
  • AMPH N/A
  • IART 4.99
  • 52 Week Low
  • AMPH $20.39
  • IART $10.87
  • 52 Week High
  • AMPH $46.43
  • IART $27.13
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 53.17
  • IART 36.89
  • Support Level
  • AMPH $23.67
  • IART $10.87
  • Resistance Level
  • AMPH $29.00
  • IART $12.73
  • Average True Range (ATR)
  • AMPH 1.38
  • IART 0.86
  • MACD
  • AMPH 0.24
  • IART -0.08
  • Stochastic Oscillator
  • AMPH 43.81
  • IART 16.46

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Share on Social Networks: